Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CSPC PHARMA (01093.HK) Subsidiary CSPC Innovation (300765.SZ) 1Q Loss Widens to RMB93.85 million
Recommend 12 Positive 21 Negative 9 |
||||
|
||||
|
CSPC PHARMA (01093.HK) announced that its subsidiary CSPC Innovation (300765.SZ) reported its first-quarter results. Revenue rose 40.8% YoY to RMB665 million. Net loss attributable to shareholders widened to RMB93.85 million from RMB26.9 million in the same period last year, with LPS of RMB0.0674. (de/d) Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
